Table 3.
GATA4 status |
P-value | ||
---|---|---|---|
+ (n = 51) | − (n = 112) | ||
Age† (years) | 53.2 ± 1.5 | 55.3 ± 1.2 | 0.30 |
Menopausal status | |||
Premenopausal | 19 | 43 | 0.89 |
Postmenopausal | 32 | 69 | |
Stage | |||
I | 10 | 31 | 0.12 |
II | 23 | 53 | |
III | 6 | 17 | |
IV | 12 | 11 | |
Pathological T factor (pT) | |||
pT1 | 15 | 42 | 0.31 |
pT2–4 | 36 | 70 | |
Lymph node metastasis | |||
Positive | 26 | 46 | 0.24 |
Negative | 25 | 66 | |
Distant metastasis | |||
Positive | 12 | 11 | 0.020 |
Negative | 39 | 101 | |
Histological grade | |||
1 (well) | 6 | 34 | 0.011 |
2 (moderate) | 22 | 49 | |
3 (poor) | 23 | 29 | |
ER status | |||
Positive | 39 | 93 | 0.32 |
Negative | 12 | 19 | |
PR LI† (%) | 18.6 ± 3.6 | 33.9 ± 3.0 | 0.0029 |
HER2 status | |||
Positive | 18 | 16 | 0.0022 |
Negative | 33 | 96 | |
Ki-67 LI† (%) | 20.5 ± 1.9 | 19.0 ± 1.8 | 0.61 |
Data are presented as mean ± SEM. All other values represent the number of cases. Statistical analysis was performed using the Student's t-test or a cross-table using the Chi-squared test. P-values < 0.05 were considered significant and are shown in bold. ER, estrogen receptor; LI, labeling index; PR, progesterone receptor.